Rheumatoid arthritis
587 results
301 - 400
Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis- Short‐term induction glucocorticoids and disease‐modifying anti‐rheumatic drugs (DMARD) therapy for rheumatoid arthritis
- Biologics for rheumatoid arthritis: an overview of Cochrane reviews
- Balneotherapy (or spa therapy) for rheumatoid arthritis
- Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
Atorvastatin = placebo for primary prevention of CV events in patients with rheumatoid arthritis- No increased risk of cancer with biologic therapy for rheumatoid arthritis
- Rofecoxib for rheumatoid arthritis
- Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
- Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis
- Antidepressants for pain management in rheumatoid arthritis: Cochrane systematic review
- Non-pharmacological interventions for fatigue in rheumatoid arthritis: Cochrane systematic review
- Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
- Short‐term glucocorticoids for flares in people with rheumatoid arthritis receiving disease‐modifying anti‐rheumatic drugs (DMARDs)
- Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand
- Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
- Cyclosporine for treating rheumatoid arthritis
- Updated ACR guideline on managing patients with rheumatoid arthritis
- MA: ultrasound is reasonably accurate in detecting synovitis in patients with rheumatoid arthritis
- Leflunomide for the treatment of rheumatoid arthritis
- Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis
- Opioid therapy for treating rheumatoid arthritis pain: Cochrane systematic review
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
- Splints and Orthosis for treating rheumatoid arthritis
- Celecoxib for rheumatoid arthritis: Cochrane systematic review
- Balance training (proprioceptive training) for patients with rheumatoid arthritis: Cochrane systematic review
Rheumatoid arthritis - Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
- Neuromodulators for pain management in rheumatoid arthritis
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
- Muscle relaxants for pain management in rheumatoid arthritis: Cochrane systematic review
- Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and rheumatoid arthritis: Cochrane systematic review
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
- Disease-specific signs and symptoms in patients with inflammatory joint diseases
- Psoriatic arthritis
- Surgical interventions for the rheumatoid shoulder
- Clinical examination of patients with joint inflammation in primary health care
- Polymyalgia rheumatica
- Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
- Adding MTX to sulfasalazine better for RA (MASCOT)
- Arthritis in children
- Disease-specific CV risk scores = general CV risk scores in patients with RA
- Limp or refusal to walk in children
- Prolonged fever of unknown origin in children
- Flu vaccine not associated with flares in patients with rheumatoid disorders
- Synovial WBC and percent PMNs best for septic arthritis diagnosis
- Guidelines: Management of RA
- Elevated ESR (hypersedimentation)
- Hand exercises modestly improve function in patients with RA (SARAH)
- Biologicals improve outcomes in patients with RA
- RA options: MTX still first-line
- RA factors + CVD risk factors modestly accurate in predicting CVD events in patients with RA
- Axial spondyloarthritis and ankylosing spondylitis
- Osteomyelitis and septic arthritis in children
- Iritis (inflammation of the iris)
- Custom-made foot orthoses for the treatment of foot pain: Cochrane systematic review
- Gout and pseudogout
- Primary Sjögren's syndrome
- MTX associated with decreased CVD risk in patients with RA
- Malocclusions of the teeth
- Leucocytosis
- Systemic lupus erythematosus (SLE)